MedPath

Oral Glucose Solution as Pain Relief in Newborns: Results of a Clinical Trial

Not Applicable
Conditions
Pain
Registration Number
NCT00847028
Lead Sponsor
Universiteit Antwerpen
Brief Summary

This study investigates which concentration of glucose is most effective in reducing pain for venipuncture in the newborn.

Detailed Description

This double-blind clinical trial is conducted on a maternity and newborn (N\*) ward. Each time, during at least one month, one of the four selected solutions (glucose 10%, 20%, 30% and placebo) will be administered orally, 2 minutes prior to the venipuncture. The pain from the skin puncture will be scored using a validated pain scale (the "Leuven" pain scale).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
304
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Pain after venipuncture measured by the Leuven pain scale for newbornssolution administration- waiting for 2 minutes-then venipuncture and immediate pain scoring
Secondary Outcome Measures
NameTimeMethod
difference in heart rhythmheart rhythm measured before painful procedure - heart rythm after venipuncture compared to baseline measurement

Trial Locations

Locations (1)

H Hart ziekenhuis

🇧🇪

Mol, Antwerp, Belgium

H Hart ziekenhuis
🇧🇪Mol, Antwerp, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.